Cargando…
Comprehensive genomic profiling for patients with chemotherapy‐naïve advanced cancer
Comprehensive genomic profiling (CGP) testing by next‐generation sequencing has been introduced into clinical practice as part of precision cancer medicine to select effective targeted therapies. However, whether CGP testing at the time of first‐line chemotherapy could be clinically useful is not cl...
Autores principales: | Kondo, Tomohiro, Matsubara, Junichi, Quy, Pham Nguyen, Fukuyama, Keita, Nomura, Motoo, Funakoshi, Taro, Doi, Keitaro, Sakamori, Yuichi, Yoshioka, Masahiro, Yokoyama, Akira, Tamaoki, Masashi, Kou, Tadayuki, Hirohashi, Kenshiro, Yamada, Atsushi, Yamamoto, Yoshihiro, Minamiguchi, Sachiko, Nishigaki, Masakazu, Yamada, Takahiro, Kanai, Masashi, Matsumoto, Shigemi, Muto, Manabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780032/ https://www.ncbi.nlm.nih.gov/pubmed/33007138 http://dx.doi.org/10.1111/cas.14674 |
Ejemplares similares
-
Inter-assay variability of next-generation sequencing-based gene panels
por: Quy, Pham Nguyen, et al.
Publicado: (2022) -
BRCA2 Reversion Mutation Identified by Liquid Biopsy After Durable Response to FOLFIRINOX in BRCA2-Associated Pancreatic Cancer
por: Kondo, Tomohiro, et al.
Publicado: (2020) -
Prevalence of pathogenic germline variants in the circulating tumor DNA testing
por: Yamamoto, Yoshihiro, et al.
Publicado: (2022) -
Cancer of unknown primary with EGFR mutation successfully treated with targeted therapy directed by clinical next-generation sequencing: a case report
por: Mitani, Yosuke, et al.
Publicado: (2020) -
Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing
por: Yamamoto, Yoshihiro, et al.
Publicado: (2019)